Similar to the findings presented in the section 3, the combination of MET and DSF-Cu (an FDA approved repurposed drug used for the treatment of alcohol abusers) also increased the expression of key apoptotic markers, Bax and p53, but at lower concentrations of MET (48). Here, TP53 is linked to alcohol abuse.